CID 71335

Danofloxacin

Structural Information

Molecular Formula
C19H20FN3O3
SMILES
CN1C[C@@H]2C[C@H]1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F
InChI
InChI=1S/C19H20FN3O3/c1-21-7-12-4-11(21)8-22(12)17-6-16-13(5-15(17)20)18(24)14(19(25)26)9-23(16)10-2-3-10/h5-6,9-12H,2-4,7-8H2,1H3,(H,25,26)/t11-,12-/m0/s1
InChIKey
QMLVECGLEOSESV-RYUDHWBXSA-N
Compound name
1-cyclopropyl-6-fluoro-7-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

210
References

4490
Patents

357.14886 Da
Monoisotopic Mass

-0.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 358.15614 187.7
[M+Na]+ 380.13808 199.1
[M-H]- 356.14158 192.5
[M+NH4]+ 375.18268 197.6
[M+K]+ 396.11202 190.6
[M+H-H2O]+ 340.14612 179.9
[M+HCOO]- 402.14706 199.9
[M+CH3COO]- 416.16271 196.7
[M+Na-2H]- 378.12353 183.8
[M]+ 357.14831 190.0
[M]- 357.14941 190.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe